Correction of the Sickle Cell Disease Mutation with CRISPR/Cas9 Description Sickle Cell Disease (SCD), one of the world’s most common genetic disorders, causes anemia and progressive multiorgan damage that typically [….]
Mike O’Mara has more than 27 years of experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell/Gene therapy manufacturing processes ranging from Preclinical/Phase I through Commercial.
Why Advanced Biomanufacturing in Maryland is a Thriving Industry These Four Industry-leading BioManufacturing Companies Represent Thousands of Jobs in Maryland and Are Shaping the Future of Medicine A burgeoning cell [….]
Bryan Poltilove is a Managing Director focused on guiding BroadOak’s growth capital investing strategy and advising portfolio companies in the life sciences and cell and gene therapy sectors.
Emergent BioSolutions to Invest $75 Million in Canton Site and Expand Viral Vector and Gene Therapy Capability June 18, 2020 Company acquires property adjacent to its Canton, Massachusetts live viral [….]
After decades of work, gene therapies promise a revolution in medicine. How can society figure out how to afford them? Join STAT reporters along with selected experts in the field [….]
Gene Editing Experts Gather at Montgomery College to Discuss Transformative Potential of CRISPR on Genomic Medicine Montgomery College’s Bioscience Education Center (BEC) is the place to be, to see and [….]
This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, [….]
Why Batten Hope Foundation is Funding Gene Therapy Clinical Trials for Children with Rare Diseases To hear Gina Hann speak about her son Joseph’s battle with an ultra-rare form of [….]
Top 10 Biotech News Stories from 2019 from the BioHealth Capital Region on biobuzz.io
